Lupus
Dr. John Cush RheumNow
5 years ago
Olmstead County (Mayo) population study shows 47 lupus nephritis (LN) pts betw 1976-2018. Incidence doubled from 1980s (0.6 per 100K) to 2018 (1.2/100K); with women of childbearing age as the most affected group. #ACR20 Abstr#0274 https://t.co/uhAMd0EtJl
k dao KDAO2011
5 years 1 month ago
Dr. C Mohan @UTSWNews #ACR20 @rheumnow reviews IFN in SLE:
👉Diff't IFN assc w/diff't lupus manifestions
👉⬆️stim endosomal DNA/RNA sensors RLR7,8,9 may drive SLE
👉TLR7 & 9 in B cells impt for germinal ctrs & Ab prod’n
👉TLR7 is X-linked
👉IFNsig not track w/dz activity https://t.co/3KK3UvH8Ka
Richard Conway RichardPAConway
5 years 1 month ago
Year in review @JYazdanyMD take home points from 2 key positive trials (finally!) in SLE this year #ACR20 @RheumNow https://t.co/74SVwNavPK
k dao KDAO2011
5 years 1 month ago
#ACR20 Abstr#0433 #PlenaryACR Georgia SLE registry 336 pts ⬆️stroke/isch heart dz with:
👉3X stroke risk and 24X IHD risk for black pts
👉predictors stroke: black race, DLE, renal dz
👉predictors IHD: age>65, black race, neuro & immuno d/o (e.g, APAs)
@RheumNow https://t.co/u6Ky7r0FYF
Bella Mehta bella_mehta
5 years 1 month ago
Plenary session 1 no#2F011 #ACR20 @rheumnow
Black #SLE patients have a 3 fold higher stroke and 24 fold higher Ishemic Heart Disease risk! https://t.co/AYtiXk7pDa
Janet Pope Janetbirdope
5 years 1 month ago
#hydroxychloroquine is not a ‘cutie’ drug. E Park et al showed that HCQ does not increase QT interval in RA & SLE patients including if on other meds that may affect QT but known heart disease excluded from study #ACR20 #ACR2020 @RheumNow abstr#432 @CRASCRRheum https://t.co/FGVPknmj5q
Mrinalini Dey DrMiniDey
5 years 1 month ago
Beautiful poster and fascinating research from @chriswincup et al showing immune cellular iron deficiency in patients with #SLE. Time to add iron supplementation as part of standard #lupus therapy?
https://t.co/Uf81KXbSM0
Abs#0294 #ACR20 @RheumNow https://t.co/z5SUjWFkdD
Mrinalini Dey DrMiniDey
5 years 1 month ago
ANA antibodies in longitudinal #SLE cohort:
- 759 patients
- 84.8% remained ANA+ve during 5yr followup period
- Pts w/ at least one -ve ANA in first 5yrs had milder disease (lower SLEDAI-2K, less steroid, fewer autoantibodies)
Abs#0251 #ACR20 @RheumNow
https://t.co/U7JbNpJA3w
k dao KDAO2011
5 years 1 month ago
Dr. G Gilkeson #Klempererlecture #ACR20 @rheumnow
There is a lupus gradient b/t Africa and US: we are seeing more SLE in the US (genetics? environmental? diet?)
Eric Dein ejdein1
5 years 1 month ago
Dr. Gilkerson in 2F010- Lupus in Unusual Places at #ACR20- Is it environmental or genetics that explain differences between African and African-Amer populations? Study the population (Sierra Leone), but do so with cultural sensitivity. @RheumNow https://t.co/B1ikkQgCuk
Janet Pope Janetbirdope
5 years 1 month ago
Do you routinely use septra/bactrim in SLE to prevent PCP/PJP? @RheumNow @CRASCRRheum
Each pharmaceutical company has spent months and years preparing to present and highlight their featured clinical trials and abstracts at ACR 2020. This is our selection of their best studies for you to review and evaluate as part of your to-do list.


Poster Hall